HK Stock Market Move | INNOGEN-B(02591) falls nearly 6% again, stock price approaching historical lows, cornerstone investors officially lifting lock-up restrictions today.

10:59 15/05/2026

Sinopharm Group-B (02591) fell nearly 6% again, hitting a low of 12.84 Hong Kong dollars, approaching the historical low of 12.16 Hong Kong dollars. As of the time of publication, it fell 5.64% to 12.88 Hong Kong dollars, with a turnover of 105.98 million Hong Kong dollars.

INNOGEN-B (02591) fell nearly 6%, hitting a low of 12.84 Hong Kong dollars, approaching the historical low of 12.16 Hong Kong dollars. As of the time of writing, it is down 5.64% at 12.88 Hong Kong dollars, with a turnover of 10.5998 million Hong Kong dollars. On the news front, according to a previous announcement by Yinuo Pharmaceuticals, the lock-up period for cornerstone investors will expire on May 14, 2026, and the related shares will be officially unlocked for trading on May 15. The cornerstone investors hold a total of 4.201 million shares. Yinuo Pharmaceuticals' financial results for the year 2025 show that the group generated approximately 131.5 million yuan in revenue; net loss was 341 million yuan, an increase of 95.4% year-on-year. Sealand pointed out that the Phase III weight reduction data for Suba is expected to be released by the end of 2026.

WALNUT CAP (00905) The comprehensive net asset value per share at the end of April is approximately HK$0.103.

MAN WAH HLDGS(01999) will distribute a final dividend of HK$0.09 per share on July 22nd.

Man Wah Holdings (01999) announced its annual performance, with a net profit attributable to shareholders of 1.812 billion Hong Kong dollars, a decrease of 12.13% year-on-year. The final dividend is 0.09 Hong Kong dollars per share.

WALNUT CAP (00905) The comprehensive net asset value per share at the end of April is approximately HK$0.103.

MAN WAH HLDGS(01999) will distribute a final dividend of HK$0.09 per share on July 22nd.